Mounjaro Powers Eli Lilly to Bumper Quarter of Earnings – The Wall Street Journal

  1. Mounjaro Powers Eli Lilly to Bumper Quarter of Earnings  The Wall Street Journal
  2. Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar  CNBC
  3. Lilly Ups Guidance on Weight Loss, Obesity Drugs’ Strength  Bloomberg.com
  4. Eli Lilly’s weight loss and diabetes drug tops Keytruda as world’s best-selling medicine  statnews.com
  5. Eli Lilly Stock Rises on Earnings and Boost to Guidance  Barron’s

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *